The Treatment of Hypertension in Patients with Erectile Dysfunction

Reference

• Jeremy JY, Mikhailidis DP (1998). Cigarette smoking and erectile dysfunction. J. Roy. Soc. Health, 118, 151–155.
   PubMedGoogle Scholar
• Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB (1994). Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J. Urol., 151, 54–61.
   PubMed Web of Science ®Google Scholar
• Chiu AVV, Chen MT, Chang LS, Chang MS (1991). Penile brachial index in impotent patients with coronary artery disease. Eur. Urol., 19, 213–216.
   PubMed Web of Science ®Google Scholar
• Grimm RH Jr, Grandis GA, Prineas RJ, et al. for the TOMHS Research Group (1997). Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS). Hypertension, 29, 8–14.
   PubMed Web of Science ®Google Scholar
• Kaplan SA, Reis RB, Kohn IJ, Shabsigh R, Te AE (1998). Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction. Urology, 52, 739–743.
   PubMed Web of Science ®Google Scholar
• Lecerof H, Bornmyr S, Lilja B, De Pedis G, Hulthen UL (1990). Acute effects of doxazosin and atenolol on smoking-induced peripheral vasoconstriction in hypertensive habitual smokers. J. Hypertens., 8 (Suppl.), S29–S33.
   Web of Science ®Google Scholar
• Muller SC, el-Damanhoury H, Ruth J, Lue TF (1991). Hypertension and impotence. Eur. Urol., 19, 29–34.
   PubMed Web of Science ®Google Scholar
• Jensen J, Lendorf A, Stimpel H, Frost J, Ibsen H, Rosenkilde P (1999). The prevalence and etiology of impotence in 101 male hypertensive outpatients. Am. J. Hypertens., 12, 271–275.
   PubMed Web of Science ®Google Scholar
• Webb DJ, Freestone S, Allen MJ, Muirhead GJ (1999). Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist. Am. J. Cardiol., 83(5A), 21C–28C.
   PubMed Web of Science ®Google Scholar
• Hansson L, Zanchetti A, Carruthers SG, et al. for the HOT Study Group (1998). Effects of intensive blood pressure lowering and low-dose aspirin in patients with hypertension: principal results of the patients with hypertension optimal treatment (HOT) randomised trial. Lancet, 351, 1755–1762.
   PubMed Web of Science ®Google Scholar
• UK prospective Diabetes Study Group (1998). Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Br. Med. J., 317, 703–713.
   PubMed Web of Science ®Google Scholar
• Lithell H (1995). Metabolic aspects of the treatment of hypertension. J. Hypertens., 13, (Suppl. 2), S77–S80.
   Google Scholar
• Shieh S-M, Sheu WH-H, Shen D-C, Fuh MM-T, Chen Y-DI, Reaven GM (1992). Glucose, insulin, and lipid metabolism in doxazosin-treated patients with hypertension. Am. J. Hypertens., 5, 827–831.
   PubMed Web of Science ®Google Scholar
• Maatman TJ, Montague DK, Martin LM (1987). Erectile dysfunction in patients with diabetes mellitus. Urology, 29, 589–592.
   PubMed Web of Science ®Google Scholar
• Cabo L, Davis PA, Cantaro S, et al. (1998). Effect of doxazosin in mild to moderate hypertensive patients with insulin-dependent diabetes mellitus. Acta Diabetol., 35, 96–100.
   PubMed Web of Science ®Google Scholar
• Shionoiri H, Ashino K, Yamanaka K, Shindo K, Hiroto S, Arita T (1997). Effect of doxazosin therapy on glucose tolerance and lipid metabolism in hypertensive patients with impaired glucose tolerance. Clin. Ther., 19, 527–536.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Svarstad E, Aanderud S, Myking OL, Lund-Johanson P. Omvik P (1998). Factors influencing reduction in blood pressure and left ventricular mass in hypertensive type-1 diabetic patients using captopril or doxazosin for 6 months. Am. J. Hypertens., 11, 1178–1187.
   PubMed Web of Science ®Google Scholar
• Giordano M, Sanders LR, Castellino P., Canessa ML, DeFronzo RA (1996). Effect of alpha-adrenergic blockers, ACE inhibitors, and calcium channel antagonists on renal function in hypertensive non-insulin-dependent diabetic patients. Nephron, 72, 447–453.
   PubMedGoogle Scholar
• Papadakis JA, Ganotakis ES, Jagroop IA, Mikhailidis DP, Winder AF (1999). Effect of hypertension, and its treatment, on lipid, lipoprotein (a), fibrinogen and bilirubin levels in patients referred for dyslipidaemia. Am. J. Hypertens., 12, 673–681.
   PubMed Web of Science ®Google Scholar
• Hedner T, Sun X (1997). Measures of endo-thelial function as an endpoint in hypertension? Blood Pressure, Suppl., 2, 58–66.
   Google Scholar
• Khan MA, Thompson CS, Sullivan ME, et al. (1998). Endothelin and erectile dysfunction: a target for pharmacological intervention? Exp. Opin. Invest. Drugs, 7, 1759–1767.
   Google Scholar
• Sullivan ME, Thompson CS, Dashwood MR, et al. (1999). Nitric oxide and penile erection: is erectile dysfunction another manifestation of vascular disease. Cardiovase. Res., 43, 658–665.
   PubMed Web of Science ®Google Scholar
• Garraway WM, Collins GN, Lee RJ (1991). High prevalence of benign prostatic hypertrophy in the community. Lancet, 338, 469–471.
   PubMed Web of Science ®Google Scholar
• Hammarsten J (1998). A new hypothesis for the aetiology of benign prostatic hyperplasia. Urol. News, 2, 11–14.
   Google Scholar
• Namasivayam S, Minhas S, Brooke J, Joyce AD, Prescott S, Eardley I (1998). The evaluation of sexual function in men presenting with symptomatic benign prostatic hyperplasia. Br. J. Urol., 82, 842–846.
   PubMedGoogle Scholar
• Grimm RH, Flack JM, Grandits GA, et al. for the Treatment of Mild Hypertension Study (TOMHS) Research Group (1996). Long-term effects on plasma lipids of diet and drugs to treat hypertension. J. Am. Med. Assoc., 275, 1549–1556.
   PubMed Web of Science ®Google Scholar
• Levy D, Walmsley P, Levenstein M (1996). Principal results of the Hypertension and Lipid Trial (HALT): A multicenter study of doxazosin in patients with hypertension. Am. Heart J., 131, 966–973.
   PubMed Web of Science ®Google Scholar
• Zehetgruber M, Christ G, Gabriel H, et al. (1998). Effect of antihypertensive treatment with doxazosin on insulin sensitivity and fibrinolytic parameters. Thromb. Haemost., 79, 378–382.
   PubMed Web of Science ®Google Scholar
• Alarayyed NA, Cooper MB, Prichard BNC, Betteridge DJ, Smith CCT (1997). In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine. Br. J. Clin. Pharmacol., 43, 415–420.
   PubMed Web of Science ®Google Scholar
• British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, British Diabetic Association. Prepared by Wood D, Durrington P, Poulter N,McInnes G, Rees A, Wray Ron behalf of the Societies (1998). Joint British recommendations on prevention of coronary heart disease in clinical practice. Heart, 80 (Suppl 2), Si–S29.
   Google Scholar